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Summary 
A murine model system was used to study the distribution and regulation of CD14 gene expression 
in vivo.  Western blot analysis  failed  to detect CD14 in plasma from untreated CB6 (BALB/c 
x  C57B16) mice, but showed markedly increased levels of CD14 in plasma from mice treated 
with lipopolysaccharide (LPS). Plasma levels of CD14 increased in a time- and dose-dependent 
manner, reaching a maximum between 8 and 16 h. Northern blot analysis of total RNA extracted 
from mouse tissues revealed low, but significant, levels of CD14 mRNA in many tissues of untreated 
animals with the highest levels in uterus, adipose tissue, and lung. After intraperitoneal injection 
of LPS, induction of CD14 gene expression was detected in all organs examined with the extent 
of induction varying between organs.  Induction of CD14  mRNA  was both  time and dose 
dependent. Maximum induction in the heart and lung was observed 2-4 h  after injection of 
LPS, while liver and kidney showed maximal induction between 8 and 16 h. In situ hybridization 
showed that CD14 mRNA was expressed in myeloid cells in many tissues,  and that expression 
in these cells was upregulated by LPS. Unexpectedly, CD14 mRNA was also detected in other 
ceils within tissues, including epithelial cells, and expression in these cell types also was upregulated 
by LPS. Immunochemical analysis revealed that CD14 antigen colocalized to the cytoplasm of 
cells expressing CD14 mRNA.  These studies demonstrate that CD14  gene expression is not 
restricted to myeloid cells, and that the level of expression of CD14 is influenced by exposure to LPS. 
E 
S,  an endotoxin found in the outer cell wall of gram- 
negative bacteria,  is a particularly potent  activator of 
myeloid cells, resulting in the production and release of im- 
munoregulatory and inflammatory mediators such as tumor 
necrosis factor-o~, interleukin-13, interleukin 6, and prosta- 
glandins (1). The excessive production of these mediators con- 
tributes to the pathophysiologic effects of LPS (2). The exis- 
tence of membrane-bound leukocyte receptors for LPS has 
been postulated and an increasing number of membrane-bound 
LPS-binding proteins have been identified (3). Of these, CD14, 
a 55-kD glycoprotein found on the cell surface of myeloid 
cells, is the only protein of fully defined structure that mediates 
LPS-induced cell activation (3). 
CD14 exists in two distinct forms: as a glycosyl-phospha- 
tidylinositol (GPI)l-anchored membrane protein (mCD14) 
and as a soluble plasma protein lacking the GPI anchor (sCD14) 
(4). Both forms appear to be involved in LPS signaling. The 
cell surface form serves as a high affinity receptor for com- 
plexes of LPS and lipopolysaccharide-binding protein, a serum 
protein which binds LPS (5). Expression of human mCD14 
1 Abbreviation used in this paper: GPI, glycosyl-phosphatidylinositol. 
in transfected murine 70Z/3 B cells (6), Chinese hamster ovary 
cells (7),  and in transgenic mice (8) has been shown to in- 
crease sensitivity to LPS. For example, responsiveness  to LPS 
was increased by as much as 1,000-fold  in the 70Z/3 B cells 
(6) and by approximately threefold in the transgenic mice 
(8). The soluble form of CD14 appears to potentiate respon- 
siveness to LPS in cells which do not express mCD14, such 
as  endothelial and epithelial cells.  LPS-responsiveness  was 
abrogated by immunodepletion of sCD14 from serum and 
could be restored by addition of sCD14 (9-11). These findings 
indicate that CD14 plays a crucial role both in the recogni- 
tion of LPS, and in the initiation of cellular responses by LPS. 
Immunological analysis has shown that mCD14 is expressed 
primarily on cells of the monocyte/macrophage lineage (re- 
viewed in reference 4), with early progenitor stem cells being 
CD14 negative and mature blood monocytes expressing high 
levels of CD14. Neutrophils also express CD14 but at lower 
levels (12). Differential expression of CD14 is also found among 
resident tissue macrophages. For example, peritoneal macro- 
phages stain strongly for CD14, while alveolar macrophages 
and microglial cells stain only weakly. CD14 antigen has also 
been detected in non-myeloid cells, namely, B cells and mam- 
mary cells (4). 
Previous studies using in vitro systems and measuring cell 
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CD14 expression but that the results obtained vary with the 
in vitro system used. For example, in purified human mono- 
cytes, LPS treatment  decreases the expression of CD14  on 
the cell surface by inducing  shedding  of the receptor into 
the conditioned medium (13). In whole blood assays,  how- 
ever, cell surface expression of CD14 on neutrophils and mono- 
cytes is upregulated by LPS (14,  15).  Upregulation is rapid 
and independent  of protein  synthesis  (14,  15). 
To date,  the potential  role of CD14  in determining  cel- 
lular responsiveness to LPS has only been studied using in 
vitro  systems.  Moreover,  the  tissue  distribution  of CD14 
mRNA  in  vivo and  its  regulation  by LPS have  not  been 
studied.  In this paper, we demonstrate that CD14 mRNA 
is detected in many murine tissues where it is produced both 
by myeloid cells and, unexpectedly, by non-myeloid cells. CD14 
mRNA  expression in  these cells is  stimulated  by LPS. 
Materials and Methods 
Experimental  Protocols.  Adult  CB6  mice  (BALB/c/ByJ  x 
C57B16/J; Scripps Clinic Rodent Breeding Colony), aged 6 to 8 wk, 
were injected intraperitoneally with 50/~g LPS (Escherichia coli sero- 
type 0111:B4; Sigma Chemical Co., St. Louis, MO) diluted in 100 
/A sterile saline (Baxter,  Deerfield,  IL). Control animals were in- 
jected with an equivalent volume of saline alone. At the conclu- 
sion  of experiments,  the  mice were anesthetized by inhalation 
anesthesia with metofane (methoxyflurane; Pitman-Moore, Mun- 
delein, IL) and exsanguinated.  The blood was collected into 20 mM 
EDTA (final concentration) to prevent clotting. Tissues were rap- 
idly removed by standard dissection  techniques,  and either minced 
and immediately frozen in liquid nitrogen for preparation of total 
RNA or fixed in paraformaldehyde for in situ hybridization and 
immunohistochemistry. 
Production  and  Characterization  of  Anti-murine  CD14  Anti- 
bodies.  Polyclonal anti-murine CD14 antibodies were prepared as 
described in Pugin et al. (16). Briefly, murine CD14 cDNA was 
obtained from RAW 264.7 cells cDNA by polymerase chain reac- 
tion. When the cDNA was expressed in the pDSpv3 prokaryotic 
expression vector, it gave rise to a protein with the NH2-terminal 
amino acid sequence and molecular weight expected of murine CD14 
(16). The solubilized recombinant protein, purified from bacterial 
lysates by reverse-phase HPLC chromatography, was used to im- 
munize New Zealand White rabbits. The resulting antiserum ap- 
peared to be specific for CD14 since FACS analysis of murine mac- 
rophage cell  lines  showed  staining  of CD14*  J774  and  RAW 
264.7 cells (16). Moreover,  Western blot analysis of supernatants 
from these cell lines treated with phosphoinositol-specific  phos- 
pholipase  C detected a strongly positive band with the mobility 
expected for CD14  (16). Finally,  immunohistochemical analysis 
showed strong staining  of J774 cells, whereas LR-9 cells which 
lack cell surface CD14 showed no staining (data  not shown). 
Western Blot Analysis.  Plasma (2 #1 per lane) was fractionated 
on 9% SDS-PAGE and transferred to Immobilon-P membranes (Mil- 
lipore Corp., Bedford, MA) (17). The membranes were soaked in 
PBS containing 5% casein for 1 h at room temperature to block 
additional protein-binding sites and then incubated at room tem- 
perature for 1 h with the polyclonal rabbit antiserum specific for 
murine CD14 (1:100 dilution in PBS containing 1% casein). The 
membranes were washed three times with PBS containing 1% casein 
and then incubated for 1 h at room temperature with 12SI-labeled 
donkey anti-rabbit  antibody (affinity  purified F(ab)2 fragment; 
Amersham Corp., Arlington, IL). The membranes were washed, 
dried,  and  autoradiography performed at  -80~  using Kodak 
XAR-5 film with intensifying screens. 
Northern Blot Analysis.  Total RNA was prepared from frozen 
tissues  by  the  acid  guanidium  thiocyanate-phenol-chloroform 
method (18) and its concentration determined by measurement of 
absorbance at 260 nm. Total RNA (10/zg) was analyzed for CD14 
mRNA by Northern blotting using standard procedures. A 1,022- 
base pair, BgllI/HindlII fragment of the murine CD14 cDNA was 
isolated and radiolabeled by the random primer technique (19) using 
[o~-32p]dGTP (>3,000 Ci/mmol; Amersham Corp.). Autoradiog- 
raphy was performed at  -80~  using Kodak XAR-5 film with 
intensifying screens. To verify equal loading and transfer of the 
RNA, Northern blots were rehybridized with a radiolabeled plasmid 
probe carrying cDNA encoding rat 18S RNA. The level of CD14 
mRNA was quantitated by densitometric analysis of Northern blot 
autoradiograms using a LKB densitometer (Ultrosan XL; LKB, 
Bromma, Sweden). 
Tissue Preparation  for In Situ Hybridization.  After removal from 
the animal,  the tissues  were immersed in  chilled  4%  (wt/vol) 
paraformaldehyde  (Sigma Chem. Co.) in 0.1 M Na phosphate, pH 
7.4, and fixed at 4~  overnight. The fixed tissues were embedded 
in paraffin blocks and sectioned at 2-5-/zm thickness using a micro- 
tome. The sections were mounted onto Superfrost/Plus  slides (Fisher 
Scientific, Pittsburgh, PA) and stored at room temperature pending 
analysis. 
Riboprobe Preparation.  A BgllI/HindlII fragment of the mouse 
CD14 cDNA, containing nucleotides 527-1549, was subcloned into 
the vector pSP73 (Promega Corp., Madison, WI). This vector was 
linearized and used as a template for in vitro transcription of radio- 
labeled antisense or sense riboprobes employing T7 or SP6 RNA 
polymerase,  respectively,  in  the  presence  of [35S]UTP (>1,200 
Ci/mmol; Amersham Corp.). Templates were removed by diges- 
tion with RQ1 DNAse (Promega) for 15 rain at 37~  and the 
riboprobes were purified by phenol extraction and ethanol precipi- 
tation. 
In Situ Hybridization.  In situ hybridizations were performed as 
described previously (20). Briefly, the paraffin-embedded tissues were 
pretreated sequentially  with xylene (3  x  5 rain), 2 x  SSC (1  x 
10 rain), paraformaldehyde (1  x  10 rain, 4~  and proteinase  K 
(1 #g/ml,  1  x  10 rain). Slides were prehybridized for 2 h in 100 
/,tl of prehybridization buffer at 42~  An additional 20/A of pre- 
hybridization buffer,  containing 2.5  mg/ml  transfer RNA  and 
600,000 cpm of the 35S-labeled riboprobe,  was added and the slides 
hybridized for 16 to 18 h at 55~  After hybridization, the slides 
were washed  with 2x  SSC (2  x  10 rain), treated with RNAse 
(20/zg/ml, 1  x  30 rain), washed in 2x  SSC (2  x  10 rain), 0.1x 
SSC (1  x  2 h) and 0.5x  SSC (2  x  10 rain). Finally, the slides 
were dehydrated by immersion in a graded alcohol series containing 
0.3 M NH4Ac, dried, coated with NTB2 emulsion (1:2 in water; 
Kodak), and exposed in the dark at 4~  for 4 to 12 wk.  Slides 
were developed for 20 rain in D19 developer (Kodak), fixed, washed 
in water,  and counterstained with hematoxylin and eosin.  Pho- 
tomicrographs were taken using bright field or polarized light 
epiluminescence. The ability of the riboprobe to recognize myeloid 
CD14 was tested using J774 cells. Strong hybridization was de- 
tected in CD14 positive cells (i.e., J774 cells) after 4 wk exposure 
but not in CD14 negative cells (i.e., 3T3 cells), even after 12 wk 
exposure  (data  not shown). 
Irnmunohistochemistry.  Immunohistochemical staining was per- 
formed as described  previously with  minor modifications  (20). 
Briefly, the paraffin-embedded  tissues were deparaffinized with xy- 
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quench endogenous peroxidase  activity, and rehydrated  by immer- 
sion in a graded series of ethanol washes. The sections were then 
permeabilized by sequential treatment with 0.2 and 0.5% Triton 
X-100 in TBS. After incubation with 10% normal goat serum for 
30 rain, the slides were incubated with the polyclonal rabbit an- 
tiserum specific  for murine CD14 (diluted 1:50 in TBS containing 
0.1% normal goat serum) for 16 to 18 h at 4~  followed by 1 h 
at room temperature. In control experiments, tissue sections were 
incubated with normal rabbit serum instead of primary antibody. 
The slides were then washed and treated sequentially with bio- 
tinylated goat anti-rabbit IgG (Zymed Labs., South San Francisco, 
CA) diluted 1:50 in PBS containing 0.05% Tween-20, streptavidin- 
peroxidase conjugate (Zymed  Labs.) and aminoethylcarbazole  chro- 
mogen containing 0.03% hydrogen peroxide (Zymed  Labs.). After 
rinsing in distilled water for 3 rain, the slides were counterstained 
with Gill modified  hematoxylin  for 20 s, rinsed  well with tap water, 
and mounted in GVA-mount (Zymed Labs.). 
Results 
Effect of LPS on Plasma Levels of CD14.  Normal human 
serum  has  been  shown to contain sCD14,  a  form of the 
receptor which migrates in SDS-PAGE as a doublet with an 
apparent molecular mass  of 48-50  kD (13). Moreover, in- 
creased levels of sCD14 have been observed in sera from septic 
or polytraumatized  patients (21). Experiments were performed 
to determine whether murine plasma contained sCD14 and 
whether it too was increased in the presence of LPS. Plasma 
was collected from control and LPS-treated mice, fraction- 
ated by electrophoresis in SDS-polyacrylamide gels under non- 
reducing conditions and electroblotted onto Immobilon-P 
membranes. CD14 was detected with a polyclonal rabbit an- 
tibody specific for murine CD14 (16). In contrast to results 
with human serum (13), no CD14 was apparent in plasma 
from control animals  (Fig.  1).  However, there was strong 
induction of CD14 in plasma from LPS-treated mice (Fig. 
1). In these studies, a single CD14 positive band with an ap- 
parent molecular mass of 48-kD was observed.  The level of 
CD14 antigen increased in response  to LPS in a dose- (Fig. 
1 B) and time- (Fig. 1 A) dependent manner, reaching a max- 
imum between 8 and 16 h. 
Tissue Distribution of  Murine CDI4 mRNA and Its Regula- 
tion by LPS.  To examine the tissue-specific expression of the 
CD14 gene in vivo, and to assess the effect of LPS on CD14 
gene expression,  mice were injected intraperitoneally either 
with 50 #g LPS (2.0 mg/kg) in saline, or with saline vehicle 
alone.  Tissues were removed 4 h later,  and total RNA was 
prepared  and analyzed for CD14 mRNA by Northern blot 
analysis. Results from the combined tissues of two mice are 
presented in Fig. 2, with the optimal autoradiographic ex- 
posure time shown for each tissue. In agreement with previous 
reports (22),  a single KNA transcript of •1.5  kb was de- 
tected. In control tissues, low, but detectable, levels of CD14 
mRNA were observed in uterus, adipose, and lung, followed 
by spleen,  heart (note the longer exposure time), thymus, 
and testes. In contrast, CD14 gene expression was barely de- 
tectable  in kidney, liver, brain, muscle, and gut. Thus, the 
level of CD14 mRNA was relatively low in control tissues 
and varied considerably between organs. After LPS treatment, 
CD14 mRNA was induced in all organs examined, with the 
extent of induction again varying between organs. For ex- 
ample, while there was moderate to strong induction in many 
tissues, there was relatively weak induction in brain, muscle 
and gut. Variations in sample loading were small as assessed 
by rehybridizing the blots with a rat  18S cDNA probe. 
To evaluate  the time course of CD14 mRNA induction 
by LPS, mice were injected with 50 #g LPS and sdected tissues 
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Figure 1.  Effect of  LPS  on 
plasma levels of CD14. Plasma 
samples (2/~1 per lane) were elec- 
trophoresed under non-reducing 
conditions  on a 9% SDS-PAGE  gel 
and  transferred to  Immobilon-P 
membranes. The membranes  were 
analyzed  by immunoblotting  using 
a  polyclonal rabbit anti-routine 
CD14 antiserum, followed  by an 
lZSI-labeled anti-rabbit antibody, 
and subjected to autoradiography. 
(A) Mice  were  injected  intraperito- 
neally  with saline  containing  50/zg 
LPS or with saline vehicle alone. 
The animals  were killed  at the in- 
dicated times and blood collected 
into 20 mM EDTA (final concen- 
tration). After centrifugation,  the 
plasma was  decanted, stored at 
-80~  and  then analyzed for 
CD14. (B) Mice  were  injected  with 
saline alone as control or with sa- 
line  containing  increasing  amounts 
of LPS as indicated.  Blood  was col- 
lected 8 h after LPS injection  and 
analyzed  for CD14 by immunoblot. Figure  2.  Induction of CD14 
mRNA  by LPS. Mice  were  injected 
intraperitoneally  with either saline 
(-) or saline  containing  50/~g  LPS 
(+). The animals were killed 4 h 
hter, total  RNA was prepared  from 
the indicated  tissues,  and 10/~g  was 
analyzed for  CD14 mRNA by 
Northern blot analysis.  Variations 
in sample  loading  were assessed  by 
rehybridizing the blots with a rat 
18S cDNA  probe. Autoradiographic 
exposure times for CD14 mRNA were varied  between tissues to permit optimal visualization  of control and induced signals and were as follows: 
brain, musde, testes, thymus,  gut, and heart, 14 d; spleen, uterus, adipose, lung, kidney,  and liver, 3 d. 
(heart, lung, liver, and kidney) were removed at various times 
and analyzed by Northern blotting (Fig. 3). The level of CD14 
mRNA in the blots was quantitated by densitometric anal- 
)'sis of the autoradiograms. In all cases, the increase in CD14 
mRNA was transient.  A  detectable increase was observed 
in heart and lung within 1 h, with maximal induction be- 
tween 2 and 4 h. Although increased levels also were detected 
in liver and kidney within 1 h, maximal levels  were not reached 
until 8 to 16 h after LPS injection. By 24 h, the level of CD14 
mRNA had returned to near basal levels  in all tissues examined. 
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Figure  3.  Time  course of induction of CD14 mRNA by LPS. Mice 
were injected  intraperitoneally  with 50 #g LPS and selected  tissues  (kidney 
[&], liver  [11], lung IV] and heart [@]) removed  at the indicated  times. 
Total RNA was prepared and analyzed  for CD14 mRNA by Northern 
blot analysis.  The concentration  ofCD14  raRNA was determined  by den- 
sitometric  analysis  of  the  blot autoradiograms.  Variations  in sample  loading 
were assessed  by rebybridizing  the blots with a rat 18S eDNA probe. The 
relative absorbance units (AU)/mm  2 were calculated by dividing the 
AU/mm  2 for CD14 mRNA  by the AU/mm  2 for 18S RNA. Points  and 
bars represent the means _+  SD of four mice. 
It was difficult to determine accurate CD14 mRNA levels 
in control tissues  because  of the very low levels of CD14 
mtLNA present, and thus, the fold induction could only be 
approximated. In spite  of these limitations, it is clear  that 
the greatest fold induction occurred in the kidney (40-  to 
80-fold),  followed by liver (30- to 40-fold), lung (15- to 41- 
fold) and heart (four- to eightfold). 
The dose dependency of the response to LPS was then ex- 
amined. Mice were injected with doses of LPS ranging from 
0.00625-50/xg  (0.25/tg-2.0  mg/kg), and selected tissues 
removed either at 2 h (heart and lung) or at 8 h  (liver and 
kidney) for analysis. Results from a representative experiment 
are shown in Fig. 4. Although CD14 mRNA increased in 
each tissue in a dose-dependent manner, differences in sensi- 
tivity were evident between the four organs examined. For 
example, in heart, lung, and liver, induction of CD14 mRNA 
could be seen with as little as 125 ng LPS, while induction 
in kidney was only evident at the higher doses of LPS (2.5 
and 50 #g). 
Cellular Localization of CD14 raRNA and Antigen  in Mu- 
rine Tissues.  In order to examine the cell-specific expression 
of CD14 mRNA in vivo, tissues from saline-injected control 
mice or LPS-treated mice were removed and fixed in parafor- 
maldehyde, and then analyzed by in situ hybridization with 
a riboprobe  specific for murine CD14.  Representative sec- 
tions from the various tissues are shown in Figs. 5-7. As ex- 
pected, CD14 mR2qA was expressed in monoey~macrophage 
derived cells in a number of tissues and its expression in these 
cells was upregulated by LPS. Examples shown here include 
Kupffer cells in control liver  (Fig.  5 a), interstitial cells in 
control kidney (Fig.  5 b), and Kupffer cells in LPS-treated 
liver (Fig. 5 c). In additional experiments (not shown), up- 
regulation was rapid, with increased expression  detected as 
early as 15 min after injection of LPS and maximal expres- 
sion within 2-4 h. Note the absence  of CD14 mRNA in 
hepatocytes in LPS-treated liver at this early time (Fig. 5 c). 
In lymphoid tissues, a positive LPS-inducible signal was ob- 
served in the red pulp of spleen and in isolated cells within 
the cortex of thymus. In connective tissue,  CD14 mR_NA 
was detected in adipose tissue and in cells within adventitial 
tissue  surrounding vessels (data not shown). 
CD14 mRNA was not detected in neutrophils from con- 
trol animals, but was strongly expressed in neutrophils after 
LPS treatment (Fig. 5 d). LPS is known to cause a profound 
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induction of  CD14 mRNA by LPS. 
Mice  were  injected  with saline  alone 
as the control (0 dose) or with sa- 
line containing increasing amounts 
of  LPS. Ttssues  were removed  after 
2 (heart and lung) or 8 h (liver and 
kidney) and total RNA was pre- 
pared  and  analyzed for  CD14 
mRNA by Northern blotting. The 
concentration of  CD14 mRNA was 
determined by densitometric anal- 
ysis of the blot  autoradiograms. 
Variations in sample loading were 
assessed  by rebybridizing the blots 
with a rat 18S cDNA probe. The 
normalized levels  of  CD14 mRNA 
are shown  in the histogram and are 
expressed as rehtive AU/mmL Au- 
toradiographic exposure times for 
CD14 mRNA were  v-aried  between 
tissues and were as follows:  heart, 
7 d; lung, 2 d; kidney  and liver, 3 d. 
neutropenia  as a result of sequestration  of the  neutrophils 
within  capillaries,  particularly  in  the lung  (1).  Neutrophil 
sequestration was seen in a number of organs (e.g., adrenals, 
bladder, uterus, and liver) and these neutrophils were shown 
to express CD14 mRNA (data not shown).  Neutrophil  se- 
questration  was particularly prominent  in lung,  where the 
massive influx of neutrophils after LPS injection showed strong 
induction of CD14 expression (Fig.  5 d).  Induction in neu- 
trophils probably accounts, in part, for the increase in CD14 
mRNA  seen in the various  tissues in response to LPS. 
Unexpectedly, CD14 mRNA also was detected within ep- 
ithelial cells from various organs (Fig. 6), and the response 
of these cells to LPS could be divided into three broad cate- 
gories.  Bronchiolar  epithelium  in lung  (Fig.  6 a)  is an ex- 
ample of the first category. In this group, epithelium from 
control animals showed a weak hybridization signal for CD14, 
and this signal was not increased after LPS treatment.  Simi- 
larly,  epithelium in bladder, stomach, and gut showed weak 
positivity that was not stimulated by LPS (data not shown). 
The second category includes epithelium that was weakly 
positive in control tissue but was markedly induced by LPS 
treatment.  Examples  of this  are transitional  epithelium  in 
kidney (Fig. 6, b and c, respectively) and bile duct epithelium 
in liver (Fig.  7, a  and c, respectively). Increased expression 
in these cell types in response to LPS was first evident at 2 h, 
peaked at 4-8  h  and returned  to near basal levels  by 24 h 
(data  not  shown). 
In the last group,  there was induction of CD14 mRNA 
expression in cells which do not appear to express CD14 under 
basal conditions. This was observed in hepatocytes (compare 
Fig. 6 d to 5 a) and in tubular epithelium in kidney (compare 
Fig.  6 e to 5  b).  CD14 mRNA was markedly increased in 
the tubules at the cortex-medulla junction but was also seen 
in the parietal cells  that  line the Bowman's capsule and in 
proximal convoluted tubules (not shown).  The response in 
hepatocytes and tubular epithelium  was delayed relative to 
that  seen in myeloid cells (compare early times  Fig.  5 c to 
later times 6 d) and was only evident  4  h  after LPS treat- 
ment.  In these cells,  CD14 mRNA increased to maximum 
levels at about 8 h,  and then declined slowly over the next 
16 h.  This slower epithelial response may account, in large 
part, for the extent of induction seen in liver and kidney and 
for the slower kinetics  seen in  these tissues. 
To check the specificity of the 3sS-labeled CD14 antisense 
riboprobe, tissue sections from liver taken 3 h after LPS treat- 
ment were hybridized with a 3sS-hbeled sense riboprobe. No 
specific hybridization was detected (compare Fig. 7 g to d). 
Immunohistochemical  staining of tissue sections from liver 
for CD14 antigen showed weak staining of Kupffer cells in 
control sections (Fig.  7 b). Increased staining of Kupffer cells 
and bile duct epithelium was observed after LPS treatment 
(Fig. 7 e). No specific staining was apparent in a parallel  sec- 
tion incubated with normal rabbit serum instead of primary 
antibody (Fig.  7 h).  Similarly,  immunohistochemical  anal- 
ysis of sections of control kidney showed staining for CD14 
antigen in interstitial cells (Fig. 7 c) and the transitional epi- 
thelium (data not shown).  Increased staining was observed 
in these cells (Fig. 7./) 3 h after LPS treatment.  In addition, 
CD14 antigen  could be detected in parietal epithelial  cells 
and in tubular epithelium 16 h after LPS treatment (Fig. 7 0- 
In addition to expression in epithelium, CD14 mRNA was 
detected in scattered cells within the heart under basal condi- 
tions (not shown) and was increased in these cells after LPS 
treatment (Fig. 6j). Once again,  induction by LPS was rapid, 
with increased expression detected as early as  15 min after 
injection of LPS and maximal expression within 2-4 h. The 
positive signal was seen in cells in the connective tissue that 
surrounds the muscle fibers,  and often in close proximity to 
erythrocytes. Their location and proximity to erythrocytes 
is consistent with the possibility that they are capillary en- 
dothelial cells. However, we have not excluded the possibility 
that  they may be mononuclear  leukocytes. 
861  Fearns  et al. Figure  5.  Localization of CD14 mRNA in myeloid cells. Sections of liver, kidney, and lung were analyzed by in situ hybridization for CD14 mRNA 
as described in Materials and Methods. (a and c) Liver sections from an untreated (x400, 8-wk exposure) and an LPS-treated (x400,  1 h LPS, 12-wk 
exposure) animal, respectively. Arrowheads indicate CD14 mRNA in Kupffer cells and H  refers to hepatocytes. (b) Section of kidney from an untreated 
animal (x400, 6-wk exposure).  Arrowheads indicate positive interstitial cells and T  identifies  tubules.  (d) Lung section from an LPS-treated  mouse 
(x400, 2 h LPS, 12-wk exposure).  Alveolar spaces are indicated by Alv. Inset, lung section at  xl,000. Arrowheads indicate positive neutrophils within 
the alveolar septa. 
Discussion 
Experimental evidence to date has shown that CD14 an- 
tigen is expressed primarily on cells of the monocyte/macro- 
phage lineage (reviewed in reference  4). In this paper, we have 
extended these studies by showing that, in the mouse, CD14 
gene expression also is detected within a number of other 
cells including epithelial cells from various organs. Although 
the level of CD14 gene expression in untreated control animals 
was relatively low, a specific and reproducible signal was de- 
tected in many of the organs examined (Fig.  2), and in situ 
hybridization analysis frequently localized it to isolated in- 
terstitial/adventitial cells within these tissues.  In addition, 
CD14 mKNA could be detected in epithelial cells in the re- 
spiratory tract (Fig.  6 a), urinary tract (Fig.  6  b), and liver 
(Fig.  7 a), as well as in the gastrointestinal and reproductive 
tracts (data not shown). 
CD14 expression in the presence of LPS has been shown 
by some to be upregulated on monocytes (15) and neutro- 
phils (14), while others have shown downregulation on mono- 
cytes or monocyte-derived macrophages (13). These studies 
measured effects on cell surface expression only and did not 
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address the effects of LPS on synthesis of CD14 mKNA. In 
a recent paper, Matsuura et al. (23) showed a time- and dose- 
dependent induction of CD14 mKNA in murine liver in re- 
sponse to LPS. Our results confirm and extend these studies. 
Our studies show that LPS is able to induce CD14 gene ex- 
pression in most tissues (Fig.  2), with highest induction in 
kidney followed by liver and lung (Fig. 3). This increase occurs 
in a time- and dose-dependent manner (Figs. 3 and 4, respec- 
tively) and is reflected by a corresponding increase in plasma 
(Fig. 1) and tissue (Fig. 7) levels of CD14 antigen. Our results 
differed from those of Matsuura et al.  (23) in that maximal 
induction in the liver was seen at 8-16 h compared to 3 h 
in their system. In addition, they were unable to detect CD14 
antigen within the parenchyma of the liver. These differences 
may reflect differences between mouse strains and LPS and 
antibody preparations, or may result from differences in fixa- 
tion procedures. 
Our experiments also demonstrate that the sensitivity to 
LPS and the kinetics of induction by LPS varied from tissue 
to tissue. For example, in lung, where induction was detected 
In Vivo Figure  6.  Localization of CD14 mRNA in epithelial cells. Sections of lung, kidney, liver, and heart were analyzed by in situ hybridization for CD14 
mRNA. (a) Section of lung (￿  400, 12-wk exposure) from an untreated animal. BE indicates the bronchiolar  epithelium and Alv identifies the alveolar 
spaces. (b) Sections of kidney from control (x 400, 12-wk exposure) and (c) LPS-treated mice (x 400, 2 h LPS, 8-wk exposure). Transitional epithelium 
is indicated by TE and the papilla region by P. T  indicates tubules.  (d) Section of LPS-treated liver (x400,  4 h LPS, 8-wk exposure). Arrowheads 
indicate Kupffer cells and H  indicates hepatocytes. (e) Section of LPS-treated kidney (x 400, 8 h LPS, 6-wk exposure). (t) Section of LPS-treated heart 
(x400,  2 h LPS, 12-wk exposure).  T, tubules. 
primarily within myeloid cells, the response to LPS was rapid. 
In contrast, induction in kidney and liver was observed pre- 
dominantly within epithelial cells and was delayed relative 
to that seen in myeloid cells. These differences raise the pos- 
sibility that induction of CD14 gene expression by LPS may 
be modulated by two distinct pathways. The initial response 
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is rapid (peaks at 2 h) and can be triggered by low doses (125 ng 
of LPS per mouse). This may be the result of a direct effect 
of LPS on the myeloid cells leading to activation of these 
cells, upregulation of cell surface receptors  and production 
of inflammatory mediators. Upregulation of a receptor by 
its own ligand has been observed with interleukin-4 (24) and interleukin-6 (IL-6) (25), with various growth factors (26--28), 
and with hormones (29-31).  According to this hypothesis, 
the initial,  rapid induction in myeloid cells is followed by 
a second, slower response (peaks at 8-16 h) in ceils that ap- 
pear to be predominantly epithelial in origin. This response 
appears to require higher concentrations of LPS (2.5 #g per 
mouse). Previous studies have shown that induction of sur- 
face CD14 expression is mediated by an IL-6 autocrine mech- 
anism in U937 cdls (32) and Mono-Mac-6 cells (33). In this 
regard, we have preliminary evidence to suggest that tumor 
necrosis factor-c~ (TNF-a) is at least partially responsible for 
the epithelial response seen in liver and kidney (our unpub- 
lished observations). Thus, the delayed response may result 
from induction of endogenous mediators such as TNF-a, 
interleukin-1, or IL-6. 
Apart from its apparent role as an LPS receptor that mediates 
activation of myeloid cells, CD14 also appears to serve as an 
opsonic receptor for LPS-coated particles. Partides opsonized 
with either LPS binding protein (34) or septin (35) bind to 
and are engulfed by phagocytes in a CD14-dependent manner, 
resulting in clearance of LPS. In both rats and rabbits, liver 
is the main clearance organ for intravenously injected LPS 
(36,  37).  Clearance from the circulation is biphasic,  with 
40-80% of the injected LPS localizing to the liver and other 
organs within minutes of injection. In the liver, the LPS is 
taken up by Kupffer cells in rabbits (37) and sinusoidal cells, 
granulocytes, and hepatocytes in rats (36).  In both species, 
there is evidence to suggest that the LPS may be cleared from 
the liver via the bile canicular system into the gut. Indeed, 
3 h after LPS injection, bile samples taken from the gall bhdder 
of rabbits contained substantial amounts of LPS, equivalent 
to that found in plasma (37).  Of interest in this regard is 
our finding that CD14 is expressed in an LPS-inducible manner 
in Kupffer cells, neutrophils, hepatocytes, and bile duct epi- 
thelium, suggesting a possible role for CD14 in the uptake 
and clearance of LPS from the body. 
Although sCD14 has been demonstrated in normal human 
serum (13) and is increased in sera from septic patients (21), 
the origin of sCD14 has yet to be determined. It has been 
assumed that sCD14 is derived from the membrane bound 
form on myeloid cells either by phospholipase cleavage of the 
GPI anchor or by protease digestion (13). It could also repre- 
sent a secreted form of the protein as is suggested by the finding 
that patients with paroxysmal nocturnal hemoglobinuria have 
normal sCD14 levels in their sera, although monocytes from 
these patients do not express CD14 on their surface (38). Our 
observations that CD14 mRNA is detected in a variety of 
cells raise the possibility that sCD14 may also originate from 
non-myeloid cells. Experiments are in progress to determine 
whether the CD14 synthesized by epithelial cells is a GPI- 
anchored protein or a secreted protein. 
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